ライフサイエンスコーパス: deficiency anemia

1 e Tg mice exhibited hepcidin excess and iron deficiency anemia.

2 elevated hepcidin levels and consequent iron deficiency anemia.

3 inguishes thalassemia-trait anemia from iron-deficiency anemia.

4 aining regimens with iron deficiency or iron deficiency anemia.

5 tion of abnormal hemoglobin to classify iron deficiency anemia.

6 s, 20%, p = 4e-7, OR = 5), particularly iron-deficiency anemia.

7 children, including iron deficiency and iron deficiency anemia.

8 05) in volunteers reporting to BCT with iron deficiency anemia.

9 causing gastrointestinal blood loss and iron deficiency anemia.

10 owing: osteoporosis or low bone mass or iron-deficiency anemia.

11 further characterization of this novel SOD2-deficiency anemia.

12 ted with a 40% reduction in the risk of iron deficiency anemia.

13 he risk of anemia, iron deficiency, and iron-deficiency anemia.

14 the benefits of successful treatment of iron deficiency anemia.

15 ause of gastrointestinal hemorrhage and iron deficiency anemia.

16 ues, while they continue to have severe iron deficiency anemia.

17 s cause gastrointestinal hemorrhage and iron deficiency anemia.

18 males and significantly associated with iron deficiency anemia.

19 ary hemochromatosis and iron-refractory iron deficiency anemia.

20 and education were not associated with iron deficiency anemia.

21 HFE mutations had a lower prevalence of iron deficiency anemia.

22 ding of thrombocytosis in patients with iron deficiency anemia.

23 %) were iron deficient; 24 of these had iron deficiency anemia.

24 r patients with rheumatoid arthritis or iron-deficiency anemia.

25 000 toddlers and 3.3 million women have iron deficiency anemia.

26 ency progresses from low iron stores to iron-deficiency anemia.

27 s have increased hematocrit and risk of iron deficiency anemia.

28 non-dialysis chronic kidney disease and iron deficiency anemia.

29 iency without anemia and about 13% have iron-deficiency anemia.

30 nd it predisposes Tfrc(Alb-Cre) mice to iron-deficiency anemia.

31 micronutrient intakes and reduction in iron deficiency anemia.

32 worldwide whose inadequate diet causes iron deficiency anemia.

33 ion in a mouse model of iron-refractory iron-deficiency anemia.

34 ncer mortality/morbidity and changes to iron-deficiency anemia.

35 nths of age in infants at high risk for iron deficiency anemia.

36 atients with unexplained, mild, chronic iron-deficiency anemia.

37 onsidered for children with nutritional iron-deficiency anemia.

38 be a safe and efficacious treatment for iron deficiency anemia.

39 , whose mutations cause iron refractory iron deficiency anemia.

40 of iron in macrophages and symptoms of iron deficiency anemia.

41 llenge the entrenched oral treatment of iron deficiency anemia.

42 ited States who do not have symptoms of iron deficiency anemia.

43 orders had been treated for concomitant iron deficiency anemia.

44 ary hemochromatosis and iron-refractory iron-deficiency anemia.

45 /L; P<0.05) and low in one patient with iron deficiency anemia.

46 appeared to be effective in correcting iron deficiency anemia.

47 important biomarker in diseases such as iron-deficiency anemia.

48 underlies erythropoietic repression in iron deficiency anemia.

49 His blood count shows signs of mild iron deficiency anemia.

50 re), and laboratory tests suggestive of iron deficiency anemia (0.5-percentage point reduction [95% C

51 owed by essential hypertension (4%) and iron deficiency anemia (3%).

52 34.7%] vs 225 women [13.6%]; P < .001), iron deficiency anemia (347 women [21.0%] vs 135 women [8.2%]

53 6 with secondary erythrocytosis, 2 with iron-deficiency anemia, 4 with hemochromatosis, or 5 normal s

54 tical improvements in the management of iron deficiency anemia, a disorder that may affect as many as

55 Consuming wildmeat may protect against iron-deficiency anemia, a serious public health problem globa

56 ons in predictors of iron deficiency or iron deficiency anemia according to iron supplementation sugg

57 tensity infection had a greater risk of iron deficiency anemia (adjusted prevalence odds ratio: 6.6;

58 Iron deficiency anemia affects >1.2 billions individuals worl

59 Iron deficiency anemia afflicts 1 in 3 individuals, mostly wo

60 one has determined the prevalence of folate-deficiency anemia after fortification.

61 Nontransgenic mice with acquired iron deficiency anemia also show thrombocytosis and Mk-biased

62 evelopment, risk of iron deficiency, or iron deficiency anemia among breastfed infants in a setting o

63 The odds of iron deficiency anemia among children aged 12-15 y were 2.95

64 for successful interventions to reduce iron deficiency anemia among food-insecure children and to im

65 study compared 96 female patients with iron-deficiency anemia and 60 healthy female control subjects

66 rther evaluation, from which those with iron-deficiency anemia and active bleeding had been excluded,

67 e of the tendency of infants to develop iron deficiency anemia and because of the documented adverse

68 ctive was to estimate the prevalence of iron deficiency anemia and examine potential reasons for this

69 els were used to identify predictors of iron deficiency anemia and iron deficiency without anemia.

70 ation of the potential contributions of iron deficiency anemia and iron treatment to this differentia

71 Hookworm infection is a major cause of iron deficiency anemia and malnutrition in developing countri

72 ifestation is epistaxis that results in iron-deficiency anemia and reduced health-related quality of

73 he association of lice infestation with iron-deficiency anemia and risk factors such as homelessness

74 n this cohort study of 24 patients with iron deficiency anemia and severe aortic stenosis, angiodyspl

75 Fe deficiency anemia and the anemia of inflammation may co-

76 ockout (Tmprss6-/-) mice, which exhibit iron deficiency anemia and thrombocytosis, we observed a Mk b

77 is gastroenterologist for evaluation of iron deficiency anemia and weight loss.

78 Both children were diagnosed with iron deficiency anemia and were suspected to have an associat

79 trolled trial focusing on patients with iron deficiency (+ /- anemia) and ND-CKD (serum ferritin < 20

80 ointestinal blood loss, and unexplained iron-deficiency anemia), and the performance of selected test

81 The disease can additionally lead to vitamin deficiencies, anemia, and osteoporosis.

82 Fifty-two percent of the subjects had iron deficiency anemia, and 30% had serum 25-hydroxyvitamin D

83 enty-five percent of all anemia, 35% of iron deficiency anemia, and 73% of severe anemia were attribu

84 y lower prevalences of iron deficiency, iron deficiency anemia, and low vitamin B-12 and, in Kenya, a

85 12.1% of children had low iron stores, iron deficiency anemia, and VA deficiency, respectively.

86 f iron fortification of food to improve iron deficiency, anemia, and biological outcomes is not prove

87 idin regulated intestinal HIF-2alpha in iron deficiency, anemia, and iron overload.

88 stores and decreasing the prevalence of iron deficiency, anemia, and vitamin A deficiency.

89 erythematosus; infections; splenectomy; iron deficiency anemia; and solid tumors such as lung cancer.

90 tanding type II diabetes, hypertension, iron deficiency anemia, aortic stenosis, and prior bariatric

91 Iron deficiency and iron-deficiency anemia are common conditions that may cause s

92 teropathy being a consequence of severe iron deficiency anemia are discussed.

93 trics recommendations for prevention of iron deficiency anemia are reviewed.

94 Iron deficiency and iron deficiency anemia are still relatively common in toddler

95 Poor iron status and iron deficiency anemia are the hallmarks of hookworm disease.

96 fect in iron absorption that results in iron-deficiency anemia, as revealed by an N-ethyl-N-nitrosour

97 ficiency among children worldwide, with iron-deficiency anemia associated with long-term adverse neur

98 erritin levels and a lower incidence of iron-deficiency anemia at 4-6 months of age.

99 nd ferritin level, iron deficiency, and iron deficiency anemia at 8 and 12 months of age.

100 ociated with decreased risk of maternal iron deficiency anemia at term (4 trials, n = 2230; 8.6% vs 1

101 comes that are associated with maternal iron deficiency anemia, both Canada and the United States rec

102 venous iron enables rapid correction of iron-deficiency anemia, but certain formulations induce fibro

103 is approved for use in the treatment of iron deficiency anemia, but it can serve as an alternative to

104 One infant developed iron deficiency anemia by 5.5 mo of age.

105 .48; 95% CI, 0.32-0.70) and the risk of iron deficiency anemia by 66% (RR, 0.34; 95% CI, 0.19-0.62).

106 However, in some CD patients, iron deficiency anemia can be persistent despite a GFD.

107 mia of chronic disease, iron refractory iron deficiency anemia, cancer, hereditary hemochromatosis, a

108 ss, studies of a murine iron-refractory iron-deficiency anemia-causing mutant (Mt2I286F) in the compl

109 emia; and had a 64% lower prevalence of iron-deficiency anemia compared with control group children.

110 Four of 8 of the deprived monkeys had iron deficiency anemia compared with none of the controls and

111 Iron-deficiency anemia, defined as low hemoglobin due to low

112 re shared with conditions such as haematinic deficiency anemias. Definitive diagnosis of MDS requires

113 is the most accurate animal model of folate deficiency anemia described to date that closely capture

114 6; CI: 0.4, 0.7), but the prevalence of iron deficiency anemia did not change significantly in childr

115 mice and Belgrade (b) rats have severe iron deficiency anemia due to defects in intestinal iron tran

116 She had a history of iron-deficiency anemia due to long-standing celiac disease th

117 es the incidence of iron deficiency and iron deficiency anemia during pregnancy, but evidence on heal

118 utine screening and supplementation for iron deficiency anemia during pregnancy.

119 ressed screening for iron deficiency or iron deficiency anemia during pregnancy.

120 rms of screening for iron deficiency or iron deficiency anemia during pregnancy.

121 for both groups and no infant developed iron deficiency anemia during the trial.

122 iron metabolism, leading to functional iron deficiency, anemia, erythropoietic protoporphyria, and a

123 re undetectable or low in patients with iron deficiency anemia (ferritin < 10 ng/mL), iron-depleted H

124 en aged 9 to 48 months with nutritional iron-deficiency anemia, ferrous sulfate compared with iron po

125 n and its great value in distinguishing iron deficiency anemia from the anemia of chronic disease.

126 deficiency (from 60% to 6%; P<0.0001), iron deficiency anemia (from 35% to 15%; P<0.007), and abnorm

127 Patients with iron-deficiency anemia had a significantly reduced choroidal

128 wildtype MDS, megaloblastic anemia, and iron deficiency anemia), Haemorasis detected over half a mill

129 India's high prevalence of iron-deficiency anemia has largely been attributed to the loc

130 5 patients aged 18 years and older with iron-deficiency anemia (hemoglobin level <=11 g/dL; serum fer

131 (HR per 1 SD, 0.85; 95% CI, 0.76-0.95), iron deficiency anemia (HR per 1 SD, 0.91; 95% CI, 0.84-0.98)

132 l that genetic variants associated with iron deficiency anemia (ICD10), obesity, type 2 diabetes, syn

133 Iron deficiency anemia (IDA) affects 50 % to 60 % of Indian w

134 Iron-deficiency anemia (IDA) affects millions of persons worl

135 s are to investigate the association of iron deficiency anemia (IDA) and FM and to find the effects o

136 s was to assess the association between iron deficiency anemia (IDA) and retinal changes via optical

137 oscopy or colonoscopy among adults with iron-deficiency anemia (IDA) and/or hematochezia have not bee

138 theast Asia, Thalassemia trait (TT) and iron deficiency anemia (IDA) are the two most common anemia t

139 Although the hazards associated with iron deficiency anemia (IDA) are well known, concerns about r

140 The effects of infantile iron deficiency anemia (IDA) extend beyond hematological indi

141 Iron deficiency anemia (IDA) has detrimental effects on indiv

142 workup fails to establish the cause of iron deficiency anemia (IDA) in a substantial proportion of p

143 utine screening and supplementation for iron deficiency anemia (IDA) in asymptomatic, nonanemic pregn

144 he actual prevalence of anemia, ID, and iron deficiency anemia (IDA) in California remains unclear.

145 tween Helicobacter pylori infection and iron deficiency anemia (IDA) in humans.

146 itis-induced achlorhydria is a cause of iron deficiency anemia (IDA) in humans.

147 the standard approach for investigating iron deficiency anemia (IDA) in men older than 45 and postmen

148 al biomarkers used for the diagnosis of iron-deficiency anemia (IDA) in patients with CKD have limita

149 in anemia of chronic disease (ACD) and iron deficiency anemia (IDA) in patients with RA.

150 is associated with iron deficiency and iron-deficiency anemia (IDA) in the United States.

151 The prevalence of iron deficiency anemia (IDA) increased over the malaria seaso

152 Iron deficiency anemia (IDA) is a major public health concern

153 When detected early in pregnancy, iron deficiency anemia (IDA) is associated with a > 2-fold in

154 d young children in Sub-Saharan Africa, iron-deficiency anemia (IDA) is common, and many complementar

155 Recognition of iron deficiency anemia (IDA) is important to initiate timely

156 Iron deficiency anemia (IDA) is relatively common in the thir

157 Preoperative iron deficiency anemia (IDA) occurs frequently; however if le

158 Iron deficiency anemia (IDA) still remains universally proble

159 prevalence of iron deficiency (ID) and iron deficiency anemia (IDA) was 10-32% and 2-5%, respectivel

160 was defined as hemoglobin < 11 g/d and iron-deficiency anemia (IDA) was defined as low ferritin, hig

161 on strategy is unclear in patients with iron deficiency anemia (IDA) who have either normal kidney fu

162 1 billion people worldwide suffer from iron deficiency anemia (IDA), a state of systemic iron insuff

163 the prevalence of iron deficiency (ID), iron deficiency anemia (IDA), and other measures of iron nutr

164 d on iron biomarker concentrations were iron deficiency anemia (IDA), anemia of inflammation (AI), an

165 tin, which was suitable for identifying iron-deficiency anemia (IDA), but less reliable than serum as

166 at delivery, and 25% (n = 5) developed iron deficiency anemia (IDA).

167 bout half of this burden is a result of iron deficiency anemia (IDA).

168 (plasma ferritin < 12 ug/L) by 56%, and iron deficiency anemia (IDA; Hb < 110 g/L and plasma ferritin

169 ciency (ID; diminished iron stores) and iron deficiency anemia (IDA; poor iron stores and diminished

170 evere complications that may arise from iron deficiency anemia if it is not recognized and treated ea

171 ion at the locus, impacting the risk of iron deficiency anemia in African Americans with specific gen

172 The treatment of iron deficiency anemia in children with inflammatory bowel di

173 ongest predictor of iron deficiency and iron deficiency anemia in children.

174 iagnostic panel for iron deficiency and iron deficiency anemia in children.

175 e beneficial impact of WIC revisions on iron deficiency anemia in children.

176 ion is associated with growth delay and iron deficiency anemia in developing countries.

177 enting and treating iron deficiency and iron deficiency anemia in infants and young children.

178 ravenous iron is commonly used to treat iron deficiency anemia in non-dialysis chronic kidney disease

179 for determining hemoglobin cutoffs for iron deficiency anemia in other populations.

180 offer a new, efficient option to treat iron deficiency anemia in patients with CKD.

181 priate for estimating the prevalence of iron deficiency anemia in poor Jamaican girls 13-14 y of age.

182 Current knowledge indicates that iron deficiency anemia in pregnancy is a risk factor for pret

183 pregnant women or routine screening for iron deficiency anemia in pregnant women or young children.

184 of benefits and harms of screening for iron deficiency anemia in pregnant women to prevent adverse m

185 disease is among the leading causes of iron-deficiency anemia in the developing world and is associa

186 todes, are currently a leading cause of iron deficiency anemia in the developing world.

187 imate prevalence of iron deficiency and iron deficiency anemia in the Jamaican girls: 7.6% and 4.3%,

188 rostate 3 (Steap3), responsible for the iron deficiency anemia in the mouse mutant nm1054.

189 and iron overload, iron deficiency, or iron deficiency anemia in the U.S. population.

190 alences of anemia, iron deficiency, and iron deficiency anemia increased in all three trial groups bu

191 ine protease mutated in iron-refractory iron deficiency anemia, inhibits hepcidin expression by dampe

192 Iron-refractory, iron-deficiency anemia (IRIDA) is a familial disorder charact

193 amilial anemia disorder iron-refractory iron deficiency anemia (IRIDA).

194 iciency (serum ferritin <12 ng/mL), and iron deficiency anemia (iron deficiency and hemoglobin <10.5

195 In particular, iron deficiency anemia is a major global health issue, but th

196 Iron deficiency anemia is common and consequential in nondial

197 n low and middle income countries where iron-deficiency anemia is highly prevalent.

198 The prevalence of iron deficiency anemia is likely to be higher in athletic pop

199 The prevalence of iron deficiency anemia is low (3%) among unsupplemented breas

200 acid fortification, the prevalence of folate-deficiency anemia is nearly nonexistent in a community-d

201 Iron deficiency anemia is one of the most serious forms of ma

202 Globally, iron deficiency anemia is the most common cause of anemia.

203 Although iron deficiency anemia is the most common human nutritional d

204 Our results may explain why iron deficiency anemia is the most pronounced early manifesta

205 ncer, and 6 to 13 percentage points for iron deficiency anemia laboratory tests suggestive of colorec

206 one, iron-restricted erythropoiesis) or iron deficiency anemia (low hepcidin).

207 Vitamin B-12 deficiency, iron-deficiency anemia, low ferritin, and low HDL were more p

208 y significant multivariate predictor of iron deficiency anemia (LRT = 30.43; P<.001).

209 n blood in the small intestine, causing iron-deficiency anemia, malnutrition, growth and development

210 ic therapy, antiangiogenic therapy, and iron deficiency anemia management across the HHT disease seve

211 duals with nonanemic iron deficiency or iron-deficiency anemia may be asymptomatic or experience fati

212 ter (P = 0.038) than did the women with iron deficiency anemia (n = 34).

213 in level, iron-deficiency (IDA) and non-iron-deficiency anemia (NIDA), and inflammatory markers.

214 Summary statistics on iron deficiency anemia, night blindness, and risk of zinc def

215 yroidism, liver disease, AIDS, coagulopathy, deficiency anemia, obesity, alcohol abuse, or drug abuse

216 asing risk of traits related to anemia (iron deficiency anemia: odds ratio [OR] scaled to a standard

217 ngle-center cohort study, patients with iron deficiency anemia on the TAVI waiting list from Septembe

218 Patients with documented iron-deficiency anemia or active gastrointestinal bleeding we

219 who are malnourished, have symptoms of iron deficiency anemia, or have special hematologic condition

220 e other major modes of presentation are iron-deficiency anemia, osteoporosis, screening of family mem

221 of SGA birth was lower in subjects with iron deficiency anemia (P = 0.002).

222 ng early development in iron-refractory iron deficiency anemia patients, who present with microcytic

223 d not improve iron status or rescue the iron deficiency anemia phenotype.

224 enal enterocytes, resulting in a severe iron deficiency anemia phenotype.

225 ed to improve iron status or rescue the iron deficiency anemia phenotype.

226 our findings from the murine models of iron deficiency anemia, primary human MEPs exhibit decreased

227 Here, we show that iron deficiency anemia refractory to oral iron therapy can be

228 erlying thrombocytosis in patients with iron deficiency anemia remain unknown.

229 lthough much of the ethnic disparity in iron deficiency anemia remains unexplained, factors associate

230 sk [RR], 0.46; 95% CI, 0.16 to 1.30) or iron deficiency anemia (RR, 0.78; 95% CI, 0.05 to 12.46) at 1

231 woman has heavy menstrual bleeding and iron-deficiency anemia.She reports nocturia and urinary frequ

232 ly the microcytic hypochromic anemia or iron deficiency anemia that is the clinical hallmark of hookw

233 substantial psychosocial morbidity and iron deficiency anemia that may be severe.

234 ut diagnosis and management of absolute iron deficiency anemia, the anemia of inflammation with funct

235 kness (CT) in the eyes of patients with iron-deficiency anemia, the most common form of the anemia, v

236 ost effective therapy of IBD-associated iron deficiency anemia, the perception of risk related to int

237 ory evaluation was notable for profound iron deficiency anemia, thrombocytosis, and hyperhomocysteine

238 hole-grain products, but would increase iron-deficiency anemia to 5.0% (95% CI: 3.9%, 6.4%).

239 inical trial in adults with NDD-CKD and iron deficiency anemia to compare the safety and efficacy of

240 n levels for diagnosing iron-refractory iron deficiency anemia to global health applications such as

241 n status across the full continuum from iron deficiency anemia to iron deficiency to iron replete to

242 n symptoms of irritable bowel syndrome, iron deficiency anemia, unexplained arthritis, and even chron

243 is a familial disorder characterized by iron deficiency anemia unresponsive to oral iron treatment bu

244 Overall, the prevalence of folate-deficiency anemia was <0.1% (1 of 1546 subjects).

245 iron supplement use, the prevalence of iron deficiency anemia was 2.3 times higher in Mexican Americ

246 ncome) >3.0, however, the prevalence of iron deficiency anemia was 2.6 +/- 0.9% in Mexican American a

247 The prevalence of iron deficiency anemia was 31% in the NI control group compar

248 The prevalence of iron deficiency anemia was 6.2 +/- 0.8% (f1.gif" BORDER="0">

249 Iron deficiency anemia was defined as abnormal results from >

250 Folate-deficiency anemia was defined as the presence of both fo

251 Iron deficiency anemia was defined as the presence of both ir

252 ring age were iron deficient; of these, iron deficiency anemia was found in 3% and 2% to 5%, respecti

253 ongest) predictor of iron deficiency or iron deficiency anemia was lower 6-mo hemoglobin.

254 The prevalence of iron deficiency anemia was lower in women who carried HFE mut

255 st administration of FCM, correction of iron deficiency anemia was observed with improved mean hemogl

256 Iron-deficiency anemia was the top cause globally, although 1

257 nia, sustained neutropenia, anemia, and iron deficiency anemia were infrequent and similar across all

258 e rates of anemia, iron deficiency, and iron deficiency anemia were significantly lower after 24 wk i

259 The best-studied example is iron deficiency anemia, which increases intestinal iron absor

260 rasitic loads increase the risk of iron (Fe) deficiency anemia, which remains prevalent globally.

261 2.7%) to 6.8% (95% CI: 4.2%, 9.3%), and iron deficiency anemia, which was 6.2% (95% CI: 3.0%, 9.3%) a

262 In 2 randomized trials of patients with iron-deficiency anemia who were intolerant of or unresponsive

263 hat newborn homozygous Pcm mice exhibit iron deficiency anemia with increased duodenal Fpn1 expressio

264 NHANES III classified iron-deficiency anemia with other nutritional anemias, a clas

265 mice (characterized by iron-refractory iron deficiency anemia) with and without adenine diet-induced

266 e prevalence of folate deficiency and folate-deficiency anemia within a sample of the Reasons for Geo

267 ith reduced risk of iron deficiency and iron deficiency anemia without a concomitant increase in the